Vaccinex, Inc. (VCNX) — SC 13D/A Filings
All SC 13D/A filings from Vaccinex, Inc.. Browse 5 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (5)
-
Zauderer Amends VaccinEx Stake Filing
— Nov 18, 2024 Risk: medium
Maurice Zauderer, filing an amendment (No. 6) to Schedule 13D on November 14, 2024, reported changes in beneficial ownership of VaccinEx, Inc. common stock. Zau -
Zauderer Amends Vaccinex Stake Filing
— Sep 20, 2024 Risk: low
Maurice Zauderer, through Vaccinex, Inc., filed an amendment (No. 5) to their Schedule 13D on September 20, 2024, regarding their holdings in VACCINEX, INC. The -
Friedberg Group Amends Stake in VaccinEx, Inc.
— Aug 7, 2024 Risk: medium
On August 7, 2024, Albert D. Friedberg and associated entities, including Friedberg Global-Macro Hedge Fund Ltd., filed an amendment (No. 11) to their Schedule -
Friedberg Group Ups Stake in VaccinEx to 5%
— Aug 1, 2024 Risk: medium
On August 1, 2024, Albert D. Friedberg and associated entities, including Friedberg Global-Macro Hedge Fund Ltd., filed an amendment to their Schedule 13D for V -
Vaccinex Insider Maurice Zauderer Updates Stock Ownership
— Feb 12, 2024 Risk: low
Maurice Zauderer, a key figure at Vaccinex, Inc., filed an Amendment No. 4 to his Schedule 13D on February 8, 2024. This filing updates his beneficial ownership
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX